Anne‐Katrin Zimmermann

TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type

Markus Rechsteiner, Anne‐Katrin Zimmermann, Peter J. Wild et al. · Experimental and Molecular Pathology · 2013 · 89 citations

Medicine, Genetics, Oncology +14

Value of immunohistochemistry in the detection of <i>BRAF^V600E</i> mutations in fine‐needle aspiration biopsies of papillary thyroid carcinoma

Anne‐Katrin Zimmermann, Ulrike Camenisch, Markus Rechsteiner et al. · Cancer Cytopathology · 2013 · 71 citations

Medicine, Oncology, Pathology +17

Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended

Spasenija Savic, Joachim Diebold, Anne‐Katrin Zimmermann et al. · Lung Cancer · 2015 · 70 citations

Medicine, Oncology, Pathology +14

Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer

Simone Brandt, Eleftherios Pierre Samartzis, Anne‐Katrin Zimmermann et al. · BMC Cancer · 2017 · 51 citations · Full text

Medicine, Oncology, Pathology +17

Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes

Aurelia Noske, Leigh A. Henricksen, Bonnie LaFleur et al. · Experimental and Molecular Pathology · 2014 · 24 citations

Medicine, Genetics, Oncology +10